Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. End Use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. The internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product Outlook
2.2.2. End Use Outlook
2.2.3. Regional Outlook
2.3. Competitive Insights
Chapter 3. Point-of-Care Glucose Testing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Point-of-Care Glucose Testing Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. Point-of-Care Glucose Testing Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Point-of-Care Glucose Testing Market: Product Movement Analysis
4.3. Point-of-Care Glucose Testing Market by Product Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.5. Professional POC Testing
4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2. Handheld Glucose Meters
4.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.3. Benchtop/Desktop Glucose Analyzers
4.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.4. Multiparameter POC Analyzers
4.5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.5. Test Strips
4.5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.6. Cartridges
4.5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.7. Reagents & Controls
4.5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.8. Lancets & Other Consumables
4.5.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Home-use/Self Testing
4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.2. Blood Glucose Meters
4.6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.3. Test Strips
4.6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.4. Lancets & Lancing Devices
4.6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.5. Other Accessories & Consumables
4.6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Point-of-Care Glucose Testing Market: End Use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Point-of-Care Glucose Testing Market: End Use Movement Analysis
5.3. Point-of-Care Glucose Testing Market by End Use Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
5.5. Institutional Channels
5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.2. Hospitals and Clinics
5.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.3. Outpatient Facilities/Ambulatory Centers
5.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.4. Long-term Care Facilities
5.5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Home-care Settings
5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Point-of-Care Glucose Testing Market: Regional Estimates & Trend Analysis
6.1. Regional Dashboard
6.2. Regional Point-of-Care Glucose Testing Market Movement Analysis
6.3. Point-of-Care Glucose Testing Market: Regional Estimates & Trend Analysis by Product & End Use
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
6.5. North America
6.5.1. North America Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.2. U.S.
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Reimbursement scenario
6.5.2.5. U.S. Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.3. Canada
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. Reimbursement scenario
6.5.3.5. Canada Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.4. Mexico
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. Reimbursement scenario
6.5.4.5. Mexico Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.5. Europe
6.5.6. Europe Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.7. UK
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Regulatory Framework
6.5.7.4. Reimbursement scenario
6.5.7.5. UK Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.8. Germany
6.5.8.1. Key Country Dynamics
6.5.8.2. Competitive Scenario
6.5.8.3. Regulatory Framework
6.5.8.4. Reimbursement scenario
6.5.8.5. Germany Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.9. France
6.5.9.1. Key Country Dynamics
6.5.9.2. Competitive Scenario
6.5.9.3. Regulatory Framework
6.5.9.4. Reimbursement scenario
6.5.9.5. France Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.10. Italy
6.5.10.1. Key Country Dynamics
6.5.10.2. Competitive Scenario
6.5.10.3. Regulatory Framework
6.5.10.4. Reimbursement scenario
6.5.10.5. Italy Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.11. Spain
6.5.11.1. Key Country Dynamics
6.5.11.2. Competitive Scenario
6.5.11.3. Regulatory Framework
6.5.11.4. Reimbursement scenario
6.5.11.5. Spain Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.12. Denmark
6.5.12.1. Key Country Dynamics
6.5.12.2. Competitive Scenario
6.5.12.3. Regulatory Framework
6.5.12.4. Reimbursement scenario
6.5.12.5. Denmark Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.13. Sweden
6.5.13.1. Key Country Dynamics
6.5.13.2. Competitive Scenario
6.5.13.3. Regulatory Framework
6.5.13.4. Reimbursement scenario
6.5.13.5. Sweden Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.14. Norway
6.5.14.1. Key Country Dynamics
6.5.14.2. Competitive Scenario
6.5.14.3. Regulatory Framework
6.5.14.4. Reimbursement scenario
6.5.14.5. Norway Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. Reimbursement scenario
6.6.2.5. Japan Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. Reimbursement scenario
6.6.3.5. China Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Regulatory Framework
6.6.4.4. Reimbursement scenario
6.6.4.5. India Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.5. South Korea
6.6.5.1. Key Country Dynamics
6.6.5.2. Competitive Scenario
6.6.5.3. Regulatory Framework
6.6.5.4. Reimbursement scenario
6.6.5.5. South Korea Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.6. Australia
6.6.6.1. Key Country Dynamics
6.6.6.2. Competitive Scenario
6.6.6.3. Regulatory Framework
6.6.6.4. Reimbursement scenario
6.6.6.5. Australia Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.7. Thailand
6.6.7.1. Key Country Dynamics
6.6.7.2. Competitive Scenario
6.6.7.3. Regulatory Framework
6.6.7.4. Reimbursement scenario
6.6.7.5. Thailand Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Latin America
6.7.1. Latin America Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. Reimbursement scenario
6.7.2.5. Brazil Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Framework
6.7.3.4. Reimbursement scenario
6.7.3.5. Argentina Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Middle East & Africa
6.8.1. Middle East & Africa Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Competitive Scenario
6.8.2.3. Regulatory Framework
6.8.2.4. Reimbursement scenario
6.8.2.5. South Africa Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Competitive Scenario
6.8.3.3. Regulatory Framework
6.8.3.4. Reimbursement scenario
6.8.3.5. Saudi Arabia Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Competitive Scenario
6.8.4.3. Regulatory Framework
6.8.4.4. Reimbursement scenario
6.8.4.5. UAE Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamics
6.8.5.2. Competitive Scenario
6.8.5.3. Regulatory Framework
6.8.5.4. Reimbursement scenario
6.8.5.5. Kuwait Point-of-Care Glucose Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Market Participant Categorization
7.2. Key Company Profiles
7.2.1. F. Hoffmann-La Roche Ltd.
7.2.1.1. Company Overview
7.2.1.2. Financial Performance
7.2.1.3. Product Benchmarking
7.2.1.4. Strategic Initiatives
7.2.2. Abbott
7.2.2.1. Company Overview
7.2.2.2. Financial Performance
7.2.2.3. Product Benchmarking
7.2.2.4. Strategic Initiatives
7.2.3. Nova Biomedical
7.2.3.1. Company Overview
7.2.3.2. Financial Performance
7.2.3.3. Product Benchmarking
7.2.3.4. Strategic Initiatives
7.2.4. LifeScan IP Holdings, LLC
7.2.4.1. Company Overview
7.2.4.2. Financial Performance
7.2.4.3. Product Benchmarking
7.2.4.4. Strategic Initiatives
7.2.5. Ascensia Diabetes Care Holdings AG
7.2.5.1. Company Overview
7.2.5.2. Financial Performance
7.2.5.3. Product Benchmarking
7.2.5.4. Strategic Initiatives
7.2.6. Trividia Health, Inc.
7.2.6.1. Company Overview
7.2.6.2. Financial Performance
7.2.6.3. Product Benchmarking
7.2.6.4. Strategic Initiatives
7.2.7. EKF Diagnostics Holdings plc
7.2.7.1. Company Overview
7.2.7.2. Financial Performance
7.2.7.3. Product Benchmarking
7.2.7.4. Strategic Initiatives
7.2.8. ARKRAY, Inc.
7.2.8.1. Company Overview
7.2.8.2. Financial Performance
7.2.8.3. Product Benchmarking
7.2.8.4. Strategic Initiatives
7.2.9. A. Menarini Diagnostics S.r.l.
7.2.9.1. Company Overview
7.2.9.2. Financial Performance
7.2.9.3. Product Benchmarking
7.2.9.4. Strategic Initiatives
7.2.10. AgaMatrix, Inc.
7.2.10.1. Company Overview
7.2.10.2. Financial Performance
7.2.10.3. Product Benchmarking
7.2.10.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 4 Global Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 5 North America Point-of-Care Glucose Testing Market, Country, 2021 - 2033 (USD Million)
Table 6 North America Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 7 North America Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 8 U.S. Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 9 U.S. Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 10 Canada Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 11 Canada Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 12 Mexico Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 13 Mexico Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 14 Europe Point-of-Care Glucose Testing Market, Country, 2021 - 2033 (USD Million)
Table 15 Europe Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 16 Europe Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 17 UK Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 18 UK Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 19 Germany Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 20 Germany Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 21 France Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 22 France Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 23 Italy Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 24 Italy Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 25 Spain Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 26 Spain Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 27 Norway Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 28 Norway Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 29 Denmark Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 30 Denmark Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 31 Sweden Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 32 Sweden Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 33 Asia Pacific Point-of-Care Glucose Testing Market, Country, 2021 - 2033 (USD Million)
Table 34 Asia Pacific Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 35 Asia Pacific Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 36 China Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 37 China Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 38 Japan Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 39 Japan Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 40 South Korea Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 41 South Korea Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 42 Thailand Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 43 Thailand Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 44 Australia Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 45 Australia Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 46 India Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 47 India Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 48 Latin America Point-of-Care Glucose Testing Market, Country, 2021 - 2033 (USD Million)
Table 49 Latin America Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 50 Latin America Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 51 Brazil Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 52 Brazil Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 53 Argentina Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 54 Argentina Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 55 Middle East & Africa Point-of-Care Glucose Testing Market, Country, 2021 - 2033 (USD Million)
Table 56 Middle East & Africa Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 57 Middle East & Africa Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 58 South Africa Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 59 South Africa Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 60 Saudi Arabia Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 61 Saudi Arabia Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 62 UAE Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 63 UAE Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
Table 64 Kuwait Point-of-Care Glucose Testing Market, Product, 2021 - 2033 (USD Million)
Table 65 Kuwait Point-of-Care Glucose Testing Market, End Use, 2021 - 2033 (USD Million)
List of Figures
Fig 1. Information procurement
Fig 2. Primary research pattern
Fig 3. Market research approaches
Fig 4. Value chain-based sizing & forecasting
Fig 5. Market formulation & validation
Fig 6. Point-of-care glucose testing market segmentation
Fig 7. Market driver analysis (Current & future impact)
Fig 8. Market restraint analysis (Current & future impact)
Fig 9. SWOT Analysis, Factor (Political & Legal, Economic and Technological)
Fig 10. Porter’s Five Forces Analysis
Fig 11. Point-of-care glucose testing market, product outlook key takeaways (USD Million)
Fig 12. Point-of-care glucose testing market: product movement analysis (USD Million), 2025 & 2033
Fig 13. Professional POC testing market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 14. Handheld glucose meters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 15. Benchtop/desktop glucose analyzers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 16. Multiparameter POC analyzers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 17. Test strips market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 18. Cartridges market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 19. Reagents & controls market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 20. Lancets & other consumables market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 21. Home-use/self testing market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 22. Blood glucose meters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 23. Test strips market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 24. Lancets & lancing devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 25. Other accessories & consumables market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 26. Point-of-care glucose testing market, end use outlook key takeaways (USD Million)
Fig 27. Point-of-care glucose testing market: end use movement analysis (USD Million), 2025 & 2033
Fig 28. Institutional channels market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 29. Hospitals and clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 30. Outpatient facilities/ambulatory centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 31. Long-term care facilities market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 32. Home-care settings market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig 33. Point-of-care glucose testing market, regional key takeaways (USD Million)
Fig 34. Point-of-care glucose testing market regional outlook, 2025 & 2033, USD Million
Fig 35. North America point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 36. U.S. point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 37. Canada point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 38. Mexico point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 39. Europe point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 40. UK point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 41. Germany point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 42. France point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 43. Italy point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 44. Spain point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 45. Denmark point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 46. Sweden point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 47. Norway point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 48. Asia Pacific point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 49. Japan point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 50. China point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 51. India point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 52. Australia point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 53. South Korea point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 54. Thailand point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 55. Latin America point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 56. Brazil point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 57. Argentina point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 58. Middle East & Africa point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 59. South Africa point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 60. Saudi Arabia point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 61. UAE point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 62. Kuwait point-of-care glucose testing market estimates and forecasts, 2021 - 2033 (USD Million)
Fig 63. List of key emerging company’s/indication disruptors/innovators